Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04267887
What this trial is testing

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
OHSU Knight Cancer Institute 7
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Testing effectiveness (Phase 2)UnknownNCT03050866
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)

Who this might be right for
Circulating Tumor CellMetastatic Prostate Cancer
Erasmus Medical Center 140
Testing effectiveness (Phase 2)Ended earlyNCT00525408
What this trial is testing

Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Cadila Pharnmaceuticals 134
Not applicableStudy completedNCT06827340
What this trial is testing

Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 104
Testing effectiveness (Phase 2)Looking for participantsNCT07529717
What this trial is testing

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 42
Not applicableStudy completedNCT01953640
What this trial is testing

Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaProstate Adenocarcinoma+1 more
Mayo Clinic 92
Not applicableStudy completedNCT06915714
What this trial is testing

The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic DiseasePET / CT
Sun Yat-sen University 45
Not applicableStudy completedNCT05415787
What this trial is testing

Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.

Who this might be right for
Circulating Tumor DNAMetastatic Prostate Cancer
University Hospital, Tours 40
Not applicableUnknownNCT05702619
What this trial is testing

Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)

Who this might be right for
Prostate CancerHypoxia
The Christie NHS Foundation Trust 60
Not applicableLooking for participantsNCT07290270
What this trial is testing

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Who this might be right for
Metastatic Prostate Cancer
Novartis Pharmaceuticals 170
Testing effectiveness (Phase 2)Study completedNCT00151073
What this trial is testing

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Who this might be right for
Hormone-Refractory Prostate Cancer
University of Michigan Rogel Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT04179864
What this trial is testing

Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Epizyme, Inc. 102
Large-scale testing (Phase 3)UnknownNCT01978873
What this trial is testing

Efficacy Study Evaluating Chemotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Örebro University, Sweden 400
Early research (Phase 1)Study completedNCT00379561
What this trial is testing

PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sophiris Bio Corp 24
Not applicableUnknownNCT02138721
What this trial is testing

Local Treatment With RP for Newly-diagnosed mPCa

Who this might be right for
Prostatic NeoplasmsNeoplasm Metastasis
University Hospital, Ghent 80
Large-scale testing (Phase 3)Study completedNCT00065442
What this trial is testing

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Dendreon 512
Not applicableLooking for participantsNCT04838899
What this trial is testing

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Who this might be right for
OligoprogressiveCastration-Resistant Prostate Cancer
Sunnybrook Health Sciences Centre 30
Testing effectiveness (Phase 2)Looking for participantsNCT06800313
What this trial is testing

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Janssen Research & Development, LLC 190
Testing effectiveness (Phase 2)Looking for participantsNCT06854250
What this trial is testing

Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sun Yat-sen University 104
Next Page